0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hyperthermia Cancer Treatment Systems Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-33G14115
Home | Market Reports | Health| Health Conditions| Cancer
Global Hyperthermia Cancer Treatment Systems Market Research Report 2023
BUY CHAPTERS

Global Hyperthermia Cancer Treatment Systems Market Research Report 2025

Code: QYRE-Auto-33G14115
Report
July 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hyperthermia Cancer Treatment Systems Market

The global market for Hyperthermia Cancer Treatment Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Hyperthermia Cancer Treatment is used to treat cancers. It is divided into local hyperthermia system and whole body hyperthermia system.
North American market for Hyperthermia Cancer Treatment Systems is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hyperthermia Cancer Treatment Systems is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hyperthermia Cancer Treatment Systems include PYREXAR Medical, Celsius43 GmbH, Hydrosun GmbH, Oncotherm Kft., Andromedic S.r.l., Yamamoto Vinita Co. Ltd, Chongqing Haifu Medical Technology Co. Ltd., innoMedicus Ltd., Gamida-Cell Ltd., RanD, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hyperthermia Cancer Treatment Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperthermia Cancer Treatment Systems.
The Hyperthermia Cancer Treatment Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hyperthermia Cancer Treatment Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hyperthermia Cancer Treatment Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hyperthermia Cancer Treatment Systems Market Report

Report Metric Details
Report Name Hyperthermia Cancer Treatment Systems Market
Segment by Type
  • Local Hyperthermia System
  • Whole Body Hyperthermia System
Segment by Application
  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Head & Neck Tumors
  • Prostate Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company PYREXAR Medical, Celsius43 GmbH, Hydrosun GmbH, Oncotherm Kft., Andromedic S.r.l., Yamamoto Vinita Co. Ltd, Chongqing Haifu Medical Technology Co. Ltd., innoMedicus Ltd., Gamida-Cell Ltd., RanD, Gentherm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hyperthermia Cancer Treatment Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hyperthermia Cancer Treatment Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Hyperthermia Cancer Treatment Systems Market report?

Ans: The main players in the Hyperthermia Cancer Treatment Systems Market are PYREXAR Medical, Celsius43 GmbH, Hydrosun GmbH, Oncotherm Kft., Andromedic S.r.l., Yamamoto Vinita Co. Ltd, Chongqing Haifu Medical Technology Co. Ltd., innoMedicus Ltd., Gamida-Cell Ltd., RanD, Gentherm

What are the Application segmentation covered in the Hyperthermia Cancer Treatment Systems Market report?

Ans: The Applications covered in the Hyperthermia Cancer Treatment Systems Market report are Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, Others

What are the Type segmentation covered in the Hyperthermia Cancer Treatment Systems Market report?

Ans: The Types covered in the Hyperthermia Cancer Treatment Systems Market report are Local Hyperthermia System, Whole Body Hyperthermia System

1 Hyperthermia Cancer Treatment Systems Market Overview
1.1 Product Definition
1.2 Hyperthermia Cancer Treatment Systems by Type
1.2.1 Global Hyperthermia Cancer Treatment Systems Market Value Comparison by Type (2024 VS 2031)
1.2.2 Local Hyperthermia System
1.2.3 Whole Body Hyperthermia System
1.3 Hyperthermia Cancer Treatment Systems by Application
1.3.1 Global Hyperthermia Cancer Treatment Systems Market Value by Application (2024 VS 2031)
1.3.2 Breast Cancer
1.3.3 Liver Cancer
1.3.4 Soft Tissue Sarcoma
1.3.5 Head & Neck Tumors
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Global Hyperthermia Cancer Treatment Systems Market Size Estimates and Forecasts
1.4.1 Global Hyperthermia Cancer Treatment Systems Revenue 2020-2031
1.4.2 Global Hyperthermia Cancer Treatment Systems Sales 2020-2031
1.4.3 Global Hyperthermia Cancer Treatment Systems Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hyperthermia Cancer Treatment Systems Market Competition by Manufacturers
2.1 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hyperthermia Cancer Treatment Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hyperthermia Cancer Treatment Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hyperthermia Cancer Treatment Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hyperthermia Cancer Treatment Systems, Product Type & Application
2.7 Global Key Manufacturers of Hyperthermia Cancer Treatment Systems, Date of Enter into This Industry
2.8 Global Hyperthermia Cancer Treatment Systems Market Competitive Situation and Trends
2.8.1 Global Hyperthermia Cancer Treatment Systems Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hyperthermia Cancer Treatment Systems Players Market Share by Revenue
2.8.3 Global Hyperthermia Cancer Treatment Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hyperthermia Cancer Treatment Systems Market Scenario by Region
3.1 Global Hyperthermia Cancer Treatment Systems Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hyperthermia Cancer Treatment Systems Sales by Region: 2020-2031
3.2.1 Global Hyperthermia Cancer Treatment Systems Sales by Region: 2020-2025
3.2.2 Global Hyperthermia Cancer Treatment Systems Sales by Region: 2026-2031
3.3 Global Hyperthermia Cancer Treatment Systems Revenue by Region: 2020-2031
3.3.1 Global Hyperthermia Cancer Treatment Systems Revenue by Region: 2020-2025
3.3.2 Global Hyperthermia Cancer Treatment Systems Revenue by Region: 2026-2031
3.4 North America Hyperthermia Cancer Treatment Systems Market Facts & Figures by Country
3.4.1 North America Hyperthermia Cancer Treatment Systems Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hyperthermia Cancer Treatment Systems Sales by Country (2020-2031)
3.4.3 North America Hyperthermia Cancer Treatment Systems Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hyperthermia Cancer Treatment Systems Market Facts & Figures by Country
3.5.1 Europe Hyperthermia Cancer Treatment Systems Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hyperthermia Cancer Treatment Systems Sales by Country (2020-2031)
3.5.3 Europe Hyperthermia Cancer Treatment Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hyperthermia Cancer Treatment Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Hyperthermia Cancer Treatment Systems Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hyperthermia Cancer Treatment Systems Market Facts & Figures by Country
3.7.1 Latin America Hyperthermia Cancer Treatment Systems Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hyperthermia Cancer Treatment Systems Sales by Country (2020-2031)
3.7.3 Latin America Hyperthermia Cancer Treatment Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hyperthermia Cancer Treatment Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Hyperthermia Cancer Treatment Systems Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hyperthermia Cancer Treatment Systems Sales by Type (2020-2031)
4.1.1 Global Hyperthermia Cancer Treatment Systems Sales by Type (2020-2025)
4.1.2 Global Hyperthermia Cancer Treatment Systems Sales by Type (2026-2031)
4.1.3 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2020-2031)
4.2 Global Hyperthermia Cancer Treatment Systems Revenue by Type (2020-2031)
4.2.1 Global Hyperthermia Cancer Treatment Systems Revenue by Type (2020-2025)
4.2.2 Global Hyperthermia Cancer Treatment Systems Revenue by Type (2026-2031)
4.2.3 Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2020-2031)
4.3 Global Hyperthermia Cancer Treatment Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hyperthermia Cancer Treatment Systems Sales by Application (2020-2031)
5.1.1 Global Hyperthermia Cancer Treatment Systems Sales by Application (2020-2025)
5.1.2 Global Hyperthermia Cancer Treatment Systems Sales by Application (2026-2031)
5.1.3 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2020-2031)
5.2 Global Hyperthermia Cancer Treatment Systems Revenue by Application (2020-2031)
5.2.1 Global Hyperthermia Cancer Treatment Systems Revenue by Application (2020-2025)
5.2.2 Global Hyperthermia Cancer Treatment Systems Revenue by Application (2026-2031)
5.2.3 Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2020-2031)
5.3 Global Hyperthermia Cancer Treatment Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 PYREXAR Medical
6.1.1 PYREXAR Medical Company Information
6.1.2 PYREXAR Medical Description and Business Overview
6.1.3 PYREXAR Medical Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 PYREXAR Medical Hyperthermia Cancer Treatment Systems Product Portfolio
6.1.5 PYREXAR Medical Recent Developments/Updates
6.2 Celsius43 GmbH
6.2.1 Celsius43 GmbH Company Information
6.2.2 Celsius43 GmbH Description and Business Overview
6.2.3 Celsius43 GmbH Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Celsius43 GmbH Hyperthermia Cancer Treatment Systems Product Portfolio
6.2.5 Celsius43 GmbH Recent Developments/Updates
6.3 Hydrosun GmbH
6.3.1 Hydrosun GmbH Company Information
6.3.2 Hydrosun GmbH Description and Business Overview
6.3.3 Hydrosun GmbH Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hydrosun GmbH Hyperthermia Cancer Treatment Systems Product Portfolio
6.3.5 Hydrosun GmbH Recent Developments/Updates
6.4 Oncotherm Kft.
6.4.1 Oncotherm Kft. Company Information
6.4.2 Oncotherm Kft. Description and Business Overview
6.4.3 Oncotherm Kft. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Oncotherm Kft. Hyperthermia Cancer Treatment Systems Product Portfolio
6.4.5 Oncotherm Kft. Recent Developments/Updates
6.5 Andromedic S.r.l.
6.5.1 Andromedic S.r.l. Company Information
6.5.2 Andromedic S.r.l. Description and Business Overview
6.5.3 Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Product Portfolio
6.5.5 Andromedic S.r.l. Recent Developments/Updates
6.6 Yamamoto Vinita Co. Ltd
6.6.1 Yamamoto Vinita Co. Ltd Company Information
6.6.2 Yamamoto Vinita Co. Ltd Description and Business Overview
6.6.3 Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Product Portfolio
6.6.5 Yamamoto Vinita Co. Ltd Recent Developments/Updates
6.7 Chongqing Haifu Medical Technology Co. Ltd.
6.7.1 Chongqing Haifu Medical Technology Co. Ltd. Company Information
6.7.2 Chongqing Haifu Medical Technology Co. Ltd. Description and Business Overview
6.7.3 Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Product Portfolio
6.7.5 Chongqing Haifu Medical Technology Co. Ltd. Recent Developments/Updates
6.8 innoMedicus Ltd.
6.8.1 innoMedicus Ltd. Company Information
6.8.2 innoMedicus Ltd. Description and Business Overview
6.8.3 innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Product Portfolio
6.8.5 innoMedicus Ltd. Recent Developments/Updates
6.9 Gamida-Cell Ltd.
6.9.1 Gamida-Cell Ltd. Company Information
6.9.2 Gamida-Cell Ltd. Description and Business Overview
6.9.3 Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Product Portfolio
6.9.5 Gamida-Cell Ltd. Recent Developments/Updates
6.10 RanD
6.10.1 RanD Company Information
6.10.2 RanD Description and Business Overview
6.10.3 RanD Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 RanD Hyperthermia Cancer Treatment Systems Product Portfolio
6.10.5 RanD Recent Developments/Updates
6.11 Gentherm
6.11.1 Gentherm Company Information
6.11.2 Gentherm Description and Business Overview
6.11.3 Gentherm Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Gentherm Hyperthermia Cancer Treatment Systems Product Portfolio
6.11.5 Gentherm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hyperthermia Cancer Treatment Systems Industry Chain Analysis
7.2 Hyperthermia Cancer Treatment Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hyperthermia Cancer Treatment Systems Production Mode & Process Analysis
7.4 Hyperthermia Cancer Treatment Systems Sales and Marketing
7.4.1 Hyperthermia Cancer Treatment Systems Sales Channels
7.4.2 Hyperthermia Cancer Treatment Systems Distributors
7.5 Hyperthermia Cancer Treatment Systems Customer Analysis
8 Hyperthermia Cancer Treatment Systems Market Dynamics
8.1 Hyperthermia Cancer Treatment Systems Industry Trends
8.2 Hyperthermia Cancer Treatment Systems Market Drivers
8.3 Hyperthermia Cancer Treatment Systems Market Challenges
8.4 Hyperthermia Cancer Treatment Systems Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hyperthermia Cancer Treatment Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hyperthermia Cancer Treatment Systems Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hyperthermia Cancer Treatment Systems Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hyperthermia Cancer Treatment Systems Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hyperthermia Cancer Treatment Systems Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hyperthermia Cancer Treatment Systems Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hyperthermia Cancer Treatment Systems Average Price (K US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hyperthermia Cancer Treatment Systems, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hyperthermia Cancer Treatment Systems, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hyperthermia Cancer Treatment Systems, Product Type & Application
 Table 12. Global Key Manufacturers of Hyperthermia Cancer Treatment Systems, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hyperthermia Cancer Treatment Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperthermia Cancer Treatment Systems as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hyperthermia Cancer Treatment Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hyperthermia Cancer Treatment Systems Sales by Region (2020-2025) & (Units)
 Table 18. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Region (2020-2025)
 Table 19. Global Hyperthermia Cancer Treatment Systems Sales by Region (2026-2031) & (Units)
 Table 20. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Region (2026-2031)
 Table 21. Global Hyperthermia Cancer Treatment Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Region (2020-2025)
 Table 23. Global Hyperthermia Cancer Treatment Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Region (2026-2031)
 Table 25. North America Hyperthermia Cancer Treatment Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hyperthermia Cancer Treatment Systems Sales by Country (2020-2025) & (Units)
 Table 27. North America Hyperthermia Cancer Treatment Systems Sales by Country (2026-2031) & (Units)
 Table 28. North America Hyperthermia Cancer Treatment Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hyperthermia Cancer Treatment Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hyperthermia Cancer Treatment Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hyperthermia Cancer Treatment Systems Sales by Country (2020-2025) & (Units)
 Table 32. Europe Hyperthermia Cancer Treatment Systems Sales by Country (2026-2031) & (Units)
 Table 33. Europe Hyperthermia Cancer Treatment Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hyperthermia Cancer Treatment Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hyperthermia Cancer Treatment Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hyperthermia Cancer Treatment Systems Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Hyperthermia Cancer Treatment Systems Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Hyperthermia Cancer Treatment Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hyperthermia Cancer Treatment Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hyperthermia Cancer Treatment Systems Sales (Units) by Type (2020-2025)
 Table 51. Global Hyperthermia Cancer Treatment Systems Sales (Units) by Type (2026-2031)
 Table 52. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2020-2025)
 Table 53. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2026-2031)
 Table 54. Global Hyperthermia Cancer Treatment Systems Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hyperthermia Cancer Treatment Systems Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2020-2025)
 Table 57. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2026-2031)
 Table 58. Global Hyperthermia Cancer Treatment Systems Price (K US$/Unit) by Type (2020-2025)
 Table 59. Global Hyperthermia Cancer Treatment Systems Price (K US$/Unit) by Type (2026-2031)
 Table 60. Global Hyperthermia Cancer Treatment Systems Sales (Units) by Application (2020-2025)
 Table 61. Global Hyperthermia Cancer Treatment Systems Sales (Units) by Application (2026-2031)
 Table 62. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2020-2025)
 Table 63. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2026-2031)
 Table 64. Global Hyperthermia Cancer Treatment Systems Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hyperthermia Cancer Treatment Systems Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2020-2025)
 Table 67. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2026-2031)
 Table 68. Global Hyperthermia Cancer Treatment Systems Price (K US$/Unit) by Application (2020-2025)
 Table 69. Global Hyperthermia Cancer Treatment Systems Price (K US$/Unit) by Application (2026-2031)
 Table 70. PYREXAR Medical Company Information
 Table 71. PYREXAR Medical Description and Business Overview
 Table 72. PYREXAR Medical Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 73. PYREXAR Medical Hyperthermia Cancer Treatment Systems Product
 Table 74. PYREXAR Medical Recent Developments/Updates
 Table 75. Celsius43 GmbH Company Information
 Table 76. Celsius43 GmbH Description and Business Overview
 Table 77. Celsius43 GmbH Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 78. Celsius43 GmbH Hyperthermia Cancer Treatment Systems Product
 Table 79. Celsius43 GmbH Recent Developments/Updates
 Table 80. Hydrosun GmbH Company Information
 Table 81. Hydrosun GmbH Description and Business Overview
 Table 82. Hydrosun GmbH Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hydrosun GmbH Hyperthermia Cancer Treatment Systems Product
 Table 84. Hydrosun GmbH Recent Developments/Updates
 Table 85. Oncotherm Kft. Company Information
 Table 86. Oncotherm Kft. Description and Business Overview
 Table 87. Oncotherm Kft. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 88. Oncotherm Kft. Hyperthermia Cancer Treatment Systems Product
 Table 89. Oncotherm Kft. Recent Developments/Updates
 Table 90. Andromedic S.r.l. Company Information
 Table 91. Andromedic S.r.l. Description and Business Overview
 Table 92. Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 93. Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Product
 Table 94. Andromedic S.r.l. Recent Developments/Updates
 Table 95. Yamamoto Vinita Co. Ltd Company Information
 Table 96. Yamamoto Vinita Co. Ltd Description and Business Overview
 Table 97. Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 98. Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Product
 Table 99. Yamamoto Vinita Co. Ltd Recent Developments/Updates
 Table 100. Chongqing Haifu Medical Technology Co. Ltd. Company Information
 Table 101. Chongqing Haifu Medical Technology Co. Ltd. Description and Business Overview
 Table 102. Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 103. Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Product
 Table 104. Chongqing Haifu Medical Technology Co. Ltd. Recent Developments/Updates
 Table 105. innoMedicus Ltd. Company Information
 Table 106. innoMedicus Ltd. Description and Business Overview
 Table 107. innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 108. innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Product
 Table 109. innoMedicus Ltd. Recent Developments/Updates
 Table 110. Gamida-Cell Ltd. Company Information
 Table 111. Gamida-Cell Ltd. Description and Business Overview
 Table 112. Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 113. Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Product
 Table 114. Gamida-Cell Ltd. Recent Developments/Updates
 Table 115. RanD Company Information
 Table 116. RanD Description and Business Overview
 Table 117. RanD Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 118. RanD Hyperthermia Cancer Treatment Systems Product
 Table 119. RanD Recent Developments/Updates
 Table 120. Gentherm Company Information
 Table 121. Gentherm Description and Business Overview
 Table 122. Gentherm Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 123. Gentherm Hyperthermia Cancer Treatment Systems Product
 Table 124. Gentherm Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Hyperthermia Cancer Treatment Systems Distributors List
 Table 128. Hyperthermia Cancer Treatment Systems Customers List
 Table 129. Hyperthermia Cancer Treatment Systems Market Trends
 Table 130. Hyperthermia Cancer Treatment Systems Market Drivers
 Table 131. Hyperthermia Cancer Treatment Systems Market Challenges
 Table 132. Hyperthermia Cancer Treatment Systems Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hyperthermia Cancer Treatment Systems
 Figure 2. Global Hyperthermia Cancer Treatment Systems Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hyperthermia Cancer Treatment Systems Market Share by Type: 2024 & 2031
 Figure 4. Local Hyperthermia System Product Picture
 Figure 5. Whole Body Hyperthermia System Product Picture
 Figure 6. Global Hyperthermia Cancer Treatment Systems Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hyperthermia Cancer Treatment Systems Market Share by Application: 2024 & 2031
 Figure 8. Breast Cancer
 Figure 9. Liver Cancer
 Figure 10. Soft Tissue Sarcoma
 Figure 11. Head & Neck Tumors
 Figure 12. Prostate Cancer
 Figure 13. Others
 Figure 14. Global Hyperthermia Cancer Treatment Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Hyperthermia Cancer Treatment Systems Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Hyperthermia Cancer Treatment Systems Sales (2020-2031) & (Units)
 Figure 17. Global Hyperthermia Cancer Treatment Systems Average Price (K US$/Unit) & (2020-2031)
 Figure 18. Hyperthermia Cancer Treatment Systems Report Years Considered
 Figure 19. Hyperthermia Cancer Treatment Systems Sales Share by Manufacturers in 2024
 Figure 20. Global Hyperthermia Cancer Treatment Systems Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Hyperthermia Cancer Treatment Systems Players: Market Share by Revenue in Hyperthermia Cancer Treatment Systems in 2024
 Figure 22. Hyperthermia Cancer Treatment Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Hyperthermia Cancer Treatment Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Hyperthermia Cancer Treatment Systems Sales Market Share by Country (2020-2031)
 Figure 25. North America Hyperthermia Cancer Treatment Systems Revenue Market Share by Country (2020-2031)
 Figure 26. United States Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Hyperthermia Cancer Treatment Systems Sales Market Share by Country (2020-2031)
 Figure 29. Europe Hyperthermia Cancer Treatment Systems Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Hyperthermia Cancer Treatment Systems Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue Market Share by Region (2020-2031)
 Figure 37. China Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Hyperthermia Cancer Treatment Systems Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Hyperthermia Cancer Treatment Systems Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Hyperthermia Cancer Treatment Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Hyperthermia Cancer Treatment Systems by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Hyperthermia Cancer Treatment Systems by Type (2020-2031)
 Figure 58. Global Hyperthermia Cancer Treatment Systems Price (K US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Hyperthermia Cancer Treatment Systems by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Hyperthermia Cancer Treatment Systems by Application (2020-2031)
 Figure 61. Global Hyperthermia Cancer Treatment Systems Price (K US$/Unit) by Application (2020-2031)
 Figure 62. Hyperthermia Cancer Treatment Systems Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart